Evidence map›Paper›PMID 40042302›Full record

ArticlemBio2025

Effects of cellular membranes and the precore protein on hepatitis B virus core particle assembly and DNA replication.

Yu-Chen Chuang, Jing-Hsiung James Ou

Abstract read
In one paragraph

Article in mBio, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Yu-Chen ChuangDepartment of Molecular Microbiology and Immunology, University of Southern California Keck School of Medicine, Los Angeles, California, USA.ORCID 0000-0001-5726-8583
Jing-Hsiung James OuDepartment of Molecular Microbiology and Immunology, University of Southern California Keck School of Medicine, Los Angeles, California, USA.ORCID 0000-0002-8274-5705

Funding

Maternal effect on offspring immunity against hepatitis B virusR01AI145813 · NIAID · UNIVERSITY OF SOUTHERN CALIFORNIA · PI AKBARI, OMID, OU, J.-H. JAMES · 2019 to 2023
$3.2M
Hepatitis B virus e antigen in viral persistenceR01AI129540 · NIAID · UNIVERSITY OF SOUTHERN CALIFORNIA · PI OU, J.-H. JAMES · 2017 to 2021
$2.1M
Autophagy and the Replication of Hepatitis B VirusR01AI148304 · NIAID · UNIVERSITY OF SOUTHERN CALIFORNIA · PI OU, J.-H. JAMES · 2020 to 2024
$2.1M
Hepatitis B virus e antigen in viral persistenceR37AI129540 · NIAID · UNIVERSITY OF SOUTHERN CALIFORNIA · PI J.-H. James Ou · 2023 to 2026
$2.0M
Molecular analysis of mother-to-child transmission of hepatitis B virusR01AI189583 · NIAID · UNIVERSITY OF SOUTHERN CALIFORNIA · PI J.-H. James Ou · 2025 to 2026
$1.2M
IL-1β as a novel therapeutic agent against hepatitis B virusR21AI179734 · NIAID · UNIVERSITY OF SOUTHERN CALIFORNIA · PI OU, J.-H. JAMES · 2024 to 2025
$445k
National Institute of Allergy and Infectious Diseases AI129540National Institute of Allergy and Infectious Diseases AI145813National Institute of Allergy and Infectious Diseases AI148304National Institute of Allergy and Infectious Diseases AI179734NIAID NIH HHS R01 AI129540NIAID NIH HHS R01 AI145813NIAID NIH HHS R01 AI148304NIAID NIH HHS R01 AI189583NIAID NIH HHS R21 AI179734NIAID NIH HHS R37 AI129540
6 · The paper itself

Abstract

Hepatitis B virus (HBV) core particle is critical for the transport and replication of the viral DNA genome. By characterizing HBV core particles in different subcellular compartments, we found that when the HBV core protein was expressed by itself, it formed core particles with a uniform and fast mobility on a non-denaturing agarose gel. However, when the core protein was expressed from a replication-competent 1.3mer HBV genome, it formed particles with more heterogeneous structures. The presence of the precore protein, a protein related to the core protein, led to the formation of chimeric particles in the cytoplasm that consisted of both precore and core proteins. When the precore protein was expressed by itself, it could also form particulate structures in association with cellular RNAs in the nucleus. Our further analysis revealed that, in cells with replicating HBV, only the fast-migrating core particles on the gel contained the viral RNA and DNA, and the membrane-associated core particles contained more mature HBV DNA than the cytosolic core particles. In addition, the precore protein reduced the level of core particle-associated HBV DNA. Interestingly, the precore protein level in the cells could be increased by the degradative autophagy inhibitor bafilomycin A1 but not by the proteasome inhibitor MG132, suggesting that autophagy might regulate the biological activities of the precore protein. In conclusion, our results indicated that membranes and the precore protein could regulate HBV core particle assembly and DNA replication and suggested a role of autophagy in the regulation of HBV precore protein activities. IMPORTANCE: Hepatitis B virus (HBV) is an important human pathogen that chronically infects 254 million people in the world. This virus contains a core particle, which plays an important role in the transport and replication of the viral DNA genome. The major protein constituent of this particle is the viral core protein. In this report, we examined how the subcellular compartments and the related precore protein might affect the core particle structure and viral DNA replication. We found that the subcellular localizations could affect the core particle assembly, and membranes and the precore protein could regulate HBV DNA replication. We also found that the inhibition of autophagic degradation increased the precore protein level, suggesting a role of autophagy in the regulation of precore protein activities. These findings provided important information for further understanding the HBV life cycle, which will aid in the development of novel drugs for the treatment of HBV patients.

Indexed as

Cell MembraneDNA ReplicationHepatitis B Core AntigensHepatitis B virusViral Core ProteinsVirus AssemblyVirus ReplicationDNA, ViralHumansDNA, ViralHepatitis B Core AntigensViral Core Proteinsautophagic degradationcore particle assemblyHBV DNA replicationhepatitis B virussubcellular fractionation

Identifiers

PMID40042302
PMCPMC11980540

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.